Matches in Wikidata for { <http://www.wikidata.org/entity/Q44014994> ?p ?o ?g. }
- Q44014994 description "2002 nî lūn-bûn" @default.
- Q44014994 description "2002年の論文" @default.
- Q44014994 description "2002年学术文章" @default.
- Q44014994 description "2002年学术文章" @default.
- Q44014994 description "2002年学术文章" @default.
- Q44014994 description "2002年学术文章" @default.
- Q44014994 description "2002年学术文章" @default.
- Q44014994 description "2002年学术文章" @default.
- Q44014994 description "2002年學術文章" @default.
- Q44014994 description "2002年學術文章" @default.
- Q44014994 description "2002年學術文章" @default.
- Q44014994 description "2002年學術文章" @default.
- Q44014994 description "2002年學術文章" @default.
- Q44014994 description "2002년 논문" @default.
- Q44014994 description "article científic" @default.
- Q44014994 description "article scientific" @default.
- Q44014994 description "article scientifique" @default.
- Q44014994 description "articol științific" @default.
- Q44014994 description "articolo scientifico" @default.
- Q44014994 description "artigo científico" @default.
- Q44014994 description "artigo científico" @default.
- Q44014994 description "artigo científico" @default.
- Q44014994 description "artikel ilmiah" @default.
- Q44014994 description "artikull shkencor" @default.
- Q44014994 description "artikulong pang-agham" @default.
- Q44014994 description "artykuł naukowy" @default.
- Q44014994 description "artículo científico publicado en 2002" @default.
- Q44014994 description "artículu científicu espublizáu en 2002" @default.
- Q44014994 description "bilimsel makale" @default.
- Q44014994 description "bài báo khoa học" @default.
- Q44014994 description "naučni članak" @default.
- Q44014994 description "scienca artikolo" @default.
- Q44014994 description "scientific article published in June 2002" @default.
- Q44014994 description "scientific article published in June 2002" @default.
- Q44014994 description "scientific article published in June 2002" @default.
- Q44014994 description "teaduslik artikkel" @default.
- Q44014994 description "tieteellinen artikkeli" @default.
- Q44014994 description "tudományos cikk" @default.
- Q44014994 description "vedecký článok" @default.
- Q44014994 description "vetenskaplig artikel" @default.
- Q44014994 description "videnskabelig artikel" @default.
- Q44014994 description "vitenskapelig artikkel" @default.
- Q44014994 description "vitskapeleg artikkel" @default.
- Q44014994 description "vědecký článek" @default.
- Q44014994 description "wetenschappelijk artikel" @default.
- Q44014994 description "wissenschaftlicher Artikel" @default.
- Q44014994 description "επιστημονικό άρθρο" @default.
- Q44014994 description "мақолаи илмӣ" @default.
- Q44014994 description "наукова стаття, опублікована в червні 2002" @default.
- Q44014994 description "научна статия" @default.
- Q44014994 description "научная статья" @default.
- Q44014994 description "научни чланак" @default.
- Q44014994 description "научни чланак" @default.
- Q44014994 description "מאמר מדעי" @default.
- Q44014994 description "مقالة علمية نشرت في يونيو 2002" @default.
- Q44014994 description "জুন ২০০২-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q44014994 description "บทความทางวิทยาศาสตร์" @default.
- Q44014994 description "სამეცნიერო სტატია" @default.
- Q44014994 name "A prospective, randomized, double-blind study of the tolerability of rifapentine 600, 900, and 1,200 mg plus isoniazid in the continuation phase of tuberculosis treatment" @default.
- Q44014994 name "A prospective, randomized, double-blind study of the tolerability of rifapentine 600, 900, and 1,200 mg plus isoniazid in the continuation phase of tuberculosis treatment" @default.
- Q44014994 type Item @default.
- Q44014994 label "A prospective, randomized, double-blind study of the tolerability of rifapentine 600, 900, and 1,200 mg plus isoniazid in the continuation phase of tuberculosis treatment" @default.
- Q44014994 label "A prospective, randomized, double-blind study of the tolerability of rifapentine 600, 900, and 1,200 mg plus isoniazid in the continuation phase of tuberculosis treatment" @default.
- Q44014994 prefLabel "A prospective, randomized, double-blind study of the tolerability of rifapentine 600, 900, and 1,200 mg plus isoniazid in the continuation phase of tuberculosis treatment" @default.
- Q44014994 prefLabel "A prospective, randomized, double-blind study of the tolerability of rifapentine 600, 900, and 1,200 mg plus isoniazid in the continuation phase of tuberculosis treatment" @default.
- Q44014994 P1433 Q44014994-E55B663F-F524-4DB5-857D-49D55B07CED0 @default.
- Q44014994 P1476 Q44014994-EA6595F5-87B1-45F3-9134-E891B97DCF2D @default.
- Q44014994 P2093 Q44014994-03106BBA-5AEC-4766-A605-5A6115CBEC35 @default.
- Q44014994 P2093 Q44014994-04813A41-E9DE-4952-8560-043984B78C07 @default.
- Q44014994 P2093 Q44014994-1AE530AB-7FEE-4EB1-9E82-ACCD7A5B2DE0 @default.
- Q44014994 P2093 Q44014994-33A7D471-B500-4DEE-82D0-AF5E2895D160 @default.
- Q44014994 P2093 Q44014994-4D6E8DDB-4F04-4B90-8B91-8953777A6C40 @default.
- Q44014994 P2093 Q44014994-4FCFBEA8-3802-4921-910F-4C0011A30FD9 @default.
- Q44014994 P2093 Q44014994-569D655C-2641-480F-A092-C93E778C0F76 @default.
- Q44014994 P2093 Q44014994-65143D56-2A4C-4B36-B16A-AA862EACA74E @default.
- Q44014994 P2093 Q44014994-A3BEF4CC-8A8D-4DF4-B0DA-6BA5A479E557 @default.
- Q44014994 P2093 Q44014994-F950AFEF-8CCF-42E2-B01A-35691401FD16 @default.
- Q44014994 P2860 Q44014994-0269B6C2-6C23-41B0-9DB9-79F0B95C57C9 @default.
- Q44014994 P2860 Q44014994-223E6B8A-ADFD-4910-89D1-012FDB363135 @default.
- Q44014994 P2860 Q44014994-71BEC51B-C62E-43FF-A41F-280C5CAFD7FB @default.
- Q44014994 P2860 Q44014994-A5A63C5C-A044-461A-8B4E-FA70B94C11C0 @default.
- Q44014994 P2860 Q44014994-A5B29F82-5DED-4464-84FA-96E610A29D80 @default.
- Q44014994 P2860 Q44014994-E49E8497-867A-4D8C-AD0C-5A13530AEA3B @default.
- Q44014994 P304 Q44014994-772E6377-E11D-4398-9DC5-90F8B1805A60 @default.
- Q44014994 P31 Q44014994-8DC9FD52-2DC8-4FB2-8849-F90D81EDDD83 @default.
- Q44014994 P356 Q44014994-ABA5AA72-8A91-4FF7-8EC5-69E24D35FCA4 @default.
- Q44014994 P407 Q44014994-93607E5D-DA87-4A8E-8210-239FD2A48C3D @default.
- Q44014994 P433 Q44014994-2E68E8B2-7E88-4B6C-97A4-CE607CF2F388 @default.
- Q44014994 P478 Q44014994-22491B36-DCE9-488C-9BF1-AFDC23A6271F @default.
- Q44014994 P577 Q44014994-0BD82BEA-D2F6-4855-8D2D-C42E23111165 @default.
- Q44014994 P698 Q44014994-8FE827EC-CD42-4E82-AA98-0FC6180FAB4F @default.
- Q44014994 P921 Q44014994-052DBC3D-5E4C-4779-AE48-6AFF04C2B4E3 @default.
- Q44014994 P921 Q44014994-59FAD70F-71FE-4D7F-8046-5C44E238CD8A @default.
- Q44014994 P921 Q44014994-A88D9CC9-7EFA-44C2-A58B-43ED87120B79 @default.
- Q44014994 P356 RCCM.200201-047OC @default.
- Q44014994 P698 12045127 @default.
- Q44014994 P1433 Q4744267 @default.
- Q44014994 P1476 "A prospective, randomized, double-blind study of the tolerability of rifapentine 600, 900, and 1,200 mg plus isoniazid in the continuation phase of tuberculosis treatment" @default.
- Q44014994 P2093 "Andrew Vernon" @default.
- Q44014994 P2093 "Ann Mosher" @default.